Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.

Carter CJ.

Neurosci Lett. 2010 Oct 11;483(2):96-100. doi: 10.1016/j.neulet.2010.07.066. Epub 2010 Jul 30. Review.

PMID:
20674675
3.

Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.

Carter CJ.

Neurochem Int. 2008 May;52(6):920-34. doi: 10.1016/j.neuint.2007.11.003. Epub 2007 Nov 23. Review.

PMID:
18164103
4.

Genetics of Alzheimer's disease: new evidences for an old hypothesis?

Lambert JC, Amouyel P.

Curr Opin Genet Dev. 2011 Jun;21(3):295-301. doi: 10.1016/j.gde.2011.02.002. Epub 2011 Mar 1. Review.

PMID:
21371880
5.

Implication of common and disease specific variants in CLU, CR1, and PICALM.

Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P.

Neurobiol Aging. 2012 Aug;33(8):1846.e7-18. doi: 10.1016/j.neurobiolaging.2012.01.110. Epub 2012 Mar 7.

PMID:
22402018
6.

Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.

Chen LH, Kao PY, Fan YH, Ho DT, Chan CS, Yik PY, Ha JC, Chu LW, Song YQ.

Neurobiol Aging. 2012 Jan;33(1):210.e1-7. doi: 10.1016/j.neurobiolaging.2011.09.016. Epub 2011 Oct 19.

PMID:
22015308
7.

Alzheimer's disease beyond APOE.

van Es MA, van den Berg LH.

Nat Genet. 2009 Oct;41(10):1047-8. doi: 10.1038/ng1009-1047. No abstract available.

PMID:
19786950
8.

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.

Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P; Alzheimer's Disease Genetics Consortium, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD.

Arch Neurol. 2010 Dec;67(12):1473-84. doi: 10.1001/archneurol.2010.201. Epub 2010 Aug 9. Erratum in: Arch Neurol. 2011 Feb;68(2):159.

9.
10.

The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.

Schjeide BM, Schnack C, Lambert JC, Lill CM, Kirchheiner J, Tumani H, Otto M, Tanzi RE, Lehrach H, Amouyel P, von Arnim CA, Bertram L.

Arch Gen Psychiatry. 2011 Feb;68(2):207-13. doi: 10.1001/archgenpsychiatry.2010.196.

PMID:
21300948
11.

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O'Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ.

Hum Mol Genet. 2010 Aug 15;19(16):3295-301. doi: 10.1093/hmg/ddq221. Epub 2010 Jun 9.

12.

Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.

Barral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, Graff-Radford N, Boeve BF, Sweet RA, Stern Y, Wilson RS, Foroud T, Ott J, Mayeux R; National Institute on Aging Late-Onset Alzheimer's Disease Genetics Study.

Neurology. 2012 May 8;78(19):1464-71. doi: 10.1212/WNL.0b013e3182553c48. Epub 2012 Apr 25.

13.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology.

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56. Review.

PMID:
22917148
14.

Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.

Wozniak MA, Mee AP, Itzhaki RF.

J Pathol. 2009 Jan;217(1):131-8. doi: 10.1002/path.2449.

PMID:
18973185
15.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
16.

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.

17.

Allele-specific polymerase chain reaction for the detection of Alzheimer's disease-related single nucleotide polymorphisms.

Darawi MN, Ai-Vyrn C, Ramasamy K, Hua PP, Pin TM, Kamaruzzaman SB, Majeed AB.

BMC Med Genet. 2013 Feb 19;14:27. doi: 10.1186/1471-2350-14-27.

18.

beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations.

McPhie DL, Golde T, Eckman CB, Yager D, Brant JB, Neve RL.

Brain Res Mol Brain Res. 2001 Dec 16;97(1):103-13.

PMID:
11744168
19.

Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.

Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC; Alzheimer's Disease Neuroimaging Initiative, Goate AM.

PLoS One. 2011 Feb 9;6(2):e15918. doi: 10.1371/journal.pone.0015918.

20.

Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.

Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC, Weamer EA, DeMichele-Sweet MA, Kuller LH.

Am J Psychiatry. 2012 Sep;169(9):954-62. doi: 10.1176/appi.ajp.2012.11121815.

Supplemental Content

Support Center